The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4716-4726

  Periyasamy, Sumudra ^a   Warrier, Manya ^a   Tillekeratne, Manoranjani P M ^a   Shou, Weinian ^b   Sanchez, Edwin R ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLOPHILIN; CYCLOSPORIN A; FK 506 BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; IMMUNOPHILIN; TACROLIMUS; WORTMANNIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; GENETIC TRANSFECTION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR INTRINSIC ACTIVITY; REPORTER GENE; WESTERN BLOTTING;

ANDROGENS; BIOLOGICAL TRANSPORT; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; CYCLOPHILINS; CYCLOSPORINE; DIHYDROTESTOSTERONE; HUMANS; IMMUNOPHILINS; LIGANDS; MALE; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 34748915685     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0145     Document Type: Article

References (86)

1. Gittes RF 1991 Carcinoma of the prostate. N Engl J Med 324:236-245
2. Denmeade SR, Isaacs JT 2002 A history of prostate cancer treatment. Nat Rev Cancer 2:389-396
3. Han G, Buchanan G, Ittmann M, Harris JM, Yu X, Demayo FJ, Tilley W, Greenberg NM 2005 Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci USA 102:1151-1156
4. Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C 2006 Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci USA 103:14477-14482
5. Feldman BJ, Feldman D 2001 The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45
6. Miyake H, Nelson C, Rennie PS, Gleave ME 2000 Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 141:2257-2265
7. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360
8. Smith DF 2004 Tetratricopeptide repeat cochaperones in steroid receptor complexes. Cell Stress Chaperones 9:109-121
9. Davies TH, Sanchez ER 2005 FKBP52. Int J Biochem Cell Biol 37:42-47
10. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E 1992 Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31:2393-2399
11. Veldscholte J, Berrevoets CA, Mulder E 1994 Studies on the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 49:341-346
12. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF 2005 Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol 19:1654-1666
13. Febbo PG, Lowenberg M, Thorner AR, Brown M, Loda M, Golub TR 2005 Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. J Urol 173:1772-1777
14. Schreiber SL, Crabtree GR 1992 The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142
15. Galat A 2003 Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem 3:1315-1347
16. Harding MW, Galat A, Uehling DE, Schreiber SL 1989 A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341:758-760
17. Xu X, Su B, Barndt RJ, Chen H, Xin H, Yan G, Chen L, Cheng D, Heitman J, Zhuang Y, Fleischer S, Shou W 2002 FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. Transplantation 73:1835-1838
18. Pratt WB, Galigniana MD, Harrell JM, DeFranco DB 2004 Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 16:857-872
19. Sanchez ER, Faber LE, Henzel WJ, Pratt WB 1990 The 56-59-kilodalton protein identified in untransformed steroid receptor complexes is a unique protein that exists in cytosol in a complex with both the 70- and 90-kilodalton heat shock proteins. Biochemistry 29:5145-5152
20. Yem AW, Tomasselli AG, Heinrikson RL, Zurcher-Neely H, Ruff VA, Johnson RA, Deibel Jr MR 1992 The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem 267:2868-2871
21. Callebaut I, Renoir JM, Lebeau MC, Massol N, Burny A, Baulieu EE, Mornon JP 1992 An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. Proc Natl Acad Sci USA 89:6270-6274
22. Tai PK, Albers MW, Chang H, Faber LE, Schreiber SL 1992 Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science 256:1315-1318
23. Peattie DA, Harding MW, Fleming MA, DeCenzo MT, Lippke JA, Livingston DJ, Benasutti M 1992 Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc Natl Acad Sci USA 89:10974-10978
24. Ning YM, Sanchez ER 1993 Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J Biol Chem 268:6073-6076
25. Renoir JM, Mercier-Bodard C, Hoffmann K, Le BS, Ning YM, Sanchez ER, Handschumacher RE, Baulieu EE 1995 Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Proc Natl Acad Sci USA 92:4977-4981
26. Davies TH, Ning YM, Sanchez ER 2005 Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 44:2030-2038
27. Tai PK, Albers MW, McDonnell DP, Chang H, Schreiber SL, Faber LE 1994 Potentiation of progesterone receptor-mediated transcription by the immunosuppressant FK506. Biochemistry 33:10666-10671
28. Edinger RS, Watkins SC, Pearce D, Johnson JP 2002 Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells. Am J Physiol Renal Physiol S 283:F254-F261
29. Milad M, Sullivan W, Diehl E, Altmann M, Nordeen S, Edwards DP, Toft DO 1995 Interaction of the progesterone receptor with binding protein for FK506 and cyclosporin A. Mol Endocrinol 9:838-847
30. Le Bihan S, Marsaud V, Mercier-Board C, Baulieu EE, Mader S, White J, Renoir JM 1998 Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Mol Endocrinol 12:986-1001
31. Ning YM, Sanchez ER 1995 Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506. J Steroid Biochem Mol Biol 52:187-194
32. Renoir JM, Le Bihan S, Mercier-Bodard C, Gold A, Arjomandi M, Radanyi C, Baulieu EE 1994 Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor. J Steroid Biochem Mol Biol 48:101-110
33. Reynolds PD, Ruan Y, Smith DF, Scammell JG 1999 Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab 84:663-669
34. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG 2000 Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141:4107-4113
35. Hubler TR, Denny WB, Valentine DL, Cheung-Flynn J, Smith DF, Scammell JG 2003 The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 144:2380-2387
36. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF 2003 The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J 22:1158-1167
37. Duina AA, Chang HC, Marsh JA, Lindquist S, Gaber RF 1996 A cyclophilin function in Hsp90-dependent signal transduction. Science 274:1713-1715
38. Davies TH, Ning YM, Sanchez ER 2002 A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277:4597-4600
39. Yong W, Yang Z, Periyasamy S, Chen H, Yucel S, Li W, Lin LY, Wolf IM, Cohn MJ, Baskin LS, Sanchez ER, Shou W 2007 Essential role for co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J Biol Chem 282:5026-5036
40. Nakao R, Haji M, Yanase T, Ogo A, Takayanagi R, Katsube T, Fukumaki Y, Nawata H 1992 A single amino acid substitution (Met786-Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome. J Clin Endocrinol Metab 74:1152-1157
41. Batch JA, Williams DM, Davies HR, Brown BD, Evans BA, Hughes IA, Patterson MN 1992 Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet 1:497-503
42. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503
43. Tan KA, De Gendt K, Atanassova N, Walker M, Sharpe RM, Saunders PT, Denolet E, Verhoeven G 2005 The role of androgens in sertoli cell proliferation and functional maturation: studies in mice with total or sertoli cell-selective ablation of the androgen receptor. Endocrinology 146:2674-2683
44. Kumar P, Mark PJ, Ward BK, Minchin RF, Ratajczak T 2001 Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem Biophys Res Commun 284:219-25
45. Zhu W, Zhang JS, Young CY 2001 Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis 22:1399-1403
46. Velasco AM, Gillis KA, Li Y, Brown EL, Sadler TM, Achilleos M, Greenberger LM, Frost P, Bai W, Zhang Y 2004 Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology 145:3913-3924
47. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM 2000 Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60:6134-6141
48. Vanaja DK, Mitchell SH, Toft DO, Young CY 2002 Effect of geldanamycin on androgen receptor function and stability. Cell Stress Chaperones 7:55-64
49. Periyasamy S, Sanchez ER 2002 Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-β through AP-1-mediated transcriptional repression. Int J Biochem Cell Biol 34:1571-1585
50. Nordeen SK, Green PPIII, Fowlkes DM 1987 A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase. DNA 6:173-178
51. Li DP, Periyasamy S, Jones TJ, Sanchez ER 2000 Heat and chemical shock potentiation of glucocorticoid receptor transactivation requires heat shock factor (HSF) activity. Modulation of HSF by vanadate and wortmannin. J Biol Chem 275:26058-26065
52. Tilley WD, Wilson CM, Marcelli M, McPhaul MJ 1990 Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 50:5382-5386
53. Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N, Loda M 2003 Intermediate basal cells of the prostate: in vitro and in vivo characterization. Prostate 55:206-218
54. Migita K, Eguchi K 2001 FK 506-mediated T-cell apoptosis induction. Transplant Proc 33:2292-2293
55. Igarashi K, Hirotani H, Woo JT, Stern PH 2004 Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Bone 35:47-56
56. Hortelano S, Castilla M, Torres AM, Tejedor A, Bosca L 2000 Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. J Am Soc Nephrol 11:2315-2323
57. Kochi S, Takanaga H, Matsuo H, Ohtani H, Naito M, Tsuruo T, Sawada Y 2000 Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci 66:2255-2260
58. Schneider G, Oswald F, Wahl C, Greten FR, Adler G, Schmid RM 2002 Cyclosporine inhibits growth through the activating transcription factor/cAMP-responsive element-binding protein binding site in the cyclin D1 promoter. J Biol Chem 277:43599-43607
59. Lin J, Adam RM, Santiestevan E, Freeman MR 1999 The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res 59:2891-2897
60. Jenster G 1999 The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 26:407-421
61. Chang CY, Walther PJ, McDonnell DP 2001 Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer. Cancer Res 61:8712-8717
62. Taneja S, Ha S, Garabedian M 2002 Androgen-stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression. J Cell Biochem 84:188-200
63. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM 1995 Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostate cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 796-803
64. Cato AC, Miksicek R, Schutz G, Arnemann J, Beato M 1986 The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J 5:2237-2240
65. Ren F, Zhang S, Mitchell SH, Butler R, Young CY 2000 Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene 19:1924-1932
66. Andrews PE, Young CY, Montgomery BT, Tindall DJ 1992 Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer Res 52:1525-1529
67. Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ 1992 Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 21:63-73
68. Ratajczak T, Ward BK, Minchin RF 2003 Immunophilin chaperones in steroid receptor signalling. Curr Top Med Chem 3:1348-1357
69. Veldscholte J, Berrevoets CA, Zegers ND, van der Kwast TH, Grootegoed JA, Mulder E 1992 Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry 31:7422-7430
70. Thomson AW 1991 The immunosuppressive macrolides FK-506 and rapamycin. Immunol Lett 29:105-111
71. Sawada S, Suzuki G, Kawase Y, Takaku F 1987 Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 139:1797-1803
72. Birge RB, Wadsworth S, Akakura R, Abeysinghe H, Kanojia R, MacIelag M, Desbarats J, Escalante M, Singh K, Sundarababu S, Parris K, Childs G, August A, Siekierka J, Weinstein DE 2004 A role for schwann cells in the neuroregenerative effects of a non-immunosuppressive fk506 derivative, jnj460. Neuroscience 124:351-366
73. Verras M, Brown J, Li X, Nusse R, Sun Z 2004 Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res 64:8860-8866
74. Shihab FS, Andoh TF, Tanner AM, Noble NA, Border WA, Franceschini N, Bennett WM 1996 Role of transforming growth factor-β 1 in experimental chronic cyclosporine nephropathy. Kidney Int 49:1141-1151
75. Wolf G, Thaiss F, Stahl RA 1995 Cyclosporine stimulates expression of transforming growth factor-β in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 60:237-241
76. van der Poel HG 2005 Androgen receptor and TGFβ1/Smad signaling are mutually inhibitory in prostate cancer. Eur Urol 48:1051-1058
77. van der Poel HG 2004 Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-β1 in prostate cancer cells. J Urol 172:1333-1337
78. Murthy S, Weigel NL 2004 1α,25-Dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor β signaling pathway. Prostate 59:282-291
79. Kahl CR, Means AR 2004 Calcineurin regulates cyclin D1 accumulation in growth-stimulated fibroblasts. Mol Biol Cell 15:1833-1842
80. Gregory CW, Johnson RTJ, Presnell SC, Mohler JL, French FS 2001 Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft. J Androl 22:537-548
81. Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW, Scher HI 1999 Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst 91:1869-1876
82. Chen Y, Martinez LA, LaCava M, Coghlan L, Conti CJ 1998 Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1. Oncogene 16:1913-1920
83. Ward BK, Mark PJ, Ingram DM, Minchin RF, Ratajczak T 1999 Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res Treat 58:267-280
84. Leverson JD, Ness SA 1998 Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol Cell 1:203-211
85. Galigniana MD, Harrell JM, Murphy PJ, Chinkers M, Radanyi C, Renoir JM, Zhang M, Pratt WB 2002 Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry 41:13602-13610
86. Galigniana MD, Morishima Y, Gallay PA, Pratt WB 2004 Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex. J Biol Chem 279:55754-55759